Tag : LateBreaking

Latest News

Positive Data from First Clinical Study of RUC-4, a Novel Subcutaneous Platelet GPIIb/IIIa Inhibitor Designed for First Point-of-Contact STEMI Therapy, Presented at AHA 2019 Late-Breaking Science Session

Newsemia
SAN DIEGO–(BUSINESS WIRE)–Data from a completed clinical study show RUC-4 provided a potent, rapid, and sustained platelet inhibition effect in stable CAD patients w/aspirin. Source...
Latest News

Reprieve Cardiovascular Announces Late-Breaking Acute Heart Failure Clinical Trial Data

Newsemia
MILFORD, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/ADHF?src=hash" target="_blank"gt;#ADHFlt;/agt;–Results of TARGET-1, TARGET-2 clinical trials presented at HF2019: Reprieve's first automated fluid management tech safe, effective for HF decongestion Source...
Latest News

Cardiac Dimensions Announces Positive Late-Breaking Results for Blinded Clinical Trial of Minimally Invasive Heart Failure Treatment

Newsemia
KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatment modalities to address heart failure and related cardiovascular conditions, announced results...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy